If good things come from above, do bad things come from below?

Por Findlay, David M
Publicado em 2010

Bone–cartilage crosstalk: a conversation for understanding osteoarthritis

Por Findlay, David M, Kuliwaba, Julia S
Publicado no Bone Res (2016)

Osteoblast-Chondrocyte Interactions in Osteoarthritis

Por Findlay, David M., Atkins, Gerald J
Publicado em 2014

Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signalling

Por Hopwood, Blair, Tsykin, Anna, Findlay, David M, Fazzalari, Nicola L
Publicado em 2007

Role of polyethylene particles in peri-prosthetic osteolysis: A review

Por Atkins, Gerald J, Haynes, David R, Howie, Donald W, Findlay, David M
Publicado em 2011

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model

Por Labrinidis, Agatha, Hay, Shelley, Liapis, Vasilios, Ponomarev, Vladimir, Findlay, David M., Evdokiou, Andreas
Publicado no Clin Cancer Res (2009)

Collecting a comprehensive evidence base to monitor fracture rehabilitation: A case study

Por Callary, Stuart A, Thewlis, Dominic, Rowlands, Alex V, Findlay, David M, Solomon, Lucian B
Publicado em 2013

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

Por Wijenayaka, Asiri R., Kogawa, Masakazu, Lim, Hui Peng, Bonewald, Lynda F., Findlay, David M., Atkins, Gerald J.
Publicado em 2011

Characterization of drug-release kinetics in trabecular bone from titania nanotube implants

Por Aw, Moom Sinn, Khalid, Kamarul A, Gulati, Karan, Atkins, Gerald J, Pivonka, Peter, Findlay, David M, Losic, Dusan
Publicado em 2012

Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo

Por Kato, Naoki, Matsumoto, Masahito, Kogawa, Masakazu, Atkins, Gerald J, Findlay, David M, Fujikawa, Takahiko, Oda, Hiromi, Ogata, Masato
Publicado em 2013

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

Por Zinonos, Irene, Labrinidis, Agatha, Lee, Michelle, Liapis, Vasilios, Hay, Shelley, Ponomarev, Vladimir, Diamond, Peter, Findlay, David M, Zannettino, Andrew CW, Evdokiou, Andreas
Publicado no J Bone Miner Res (2011)

Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism

Por Atkins, Gerald J, Rowe, Peter S, Lim, Hui P, Welldon, Katie J, Ormsby, Renee, Wijenayaka, Asiri R, Zelenchuk, Lesya, Evdokiou, Andreas, Findlay, David M
Publicado em 2011

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

Por Zinonos, Irene, Labrinidis, Agatha, Lee, Michelle, Liapis, Vasilios, Hay, Shelley, Ponomarev, Vladimir, Diamond, Peter, Zannettino, Andrew C.W., Findlay, David M., Evdokiou, Andreas
Publicado no Mol Cancer Ther (2009)

HYPOXIA-ACTIVATED PRO-DRUG TH-302 EXHIBITS POTENT TUMOUR SUPPRESSIVE ACTIVITY AND COOPERATES WITH CHEMOTHERAPY AGAINST OSTEOSARCOMA

Por Liapis, Vasilios, Labrinidis, Agatha, Zinonos, Irene, Hay, Shelley, Ponomarev, Vladimir, Panagopoulos, Vasilios, DeNichilo, Mark, Ingman, Wendy, Atkins, Gerald J., Findlay, David M., Zannettino, Andrew CW., Evdokiou, Andreas
Publicado no Cancer Lett (2014)

Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium

Por Dharmapatni, Anak ASSK, Smith, Malcolm D, Findlay, David M, Holding, Christopher A, Evdokiou, Andreas, Ahern, Michael J, Weedon, Helen, Chen, Paul, Screaton, Gavin, Xu, Xiao N, Haynes, David R
Publicado em 2009

TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis

Por Dharmapatni, Anak ASSK, Smith, Malcolm D, Crotti, Tania N, Holding, Christopher A, Vincent, Cristina, Weedon, Helen M, Zannettino, Andrew CW, Zheng, Timothy S, Findlay, David M, Atkins, Gerald J, Haynes, David R
Publicado em 2011

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models

Por Liapis, Vasilios, Zinonos, Irene, Labrinidis, Agatha, Hay, Shelley, Ponomarev, Vladimir, Panagopoulos, Vasilios, Zysk, Aneta, DeNichilo, Mark, Ingman, Wendy, Atkins, Gerald J., Findlay, David M., Zannettino, Andrew C. W., Evdokiou, Andreas
Publicado no Cancer Med (2016)

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

Por Labrinidis, Agatha, Diamond, Peter, Martin, Sally, Hay, Shelley, Liapis, Vasilios, Zinonos, Irene, Sims, Natalie A., Atkins, Gerald J., Vincent, Cristina, Ponomarev, Vladimir, Findlay, David M., Zannettino, Andrew C.W., Evdokiou, Andreas
Publicado no Clin Cancer Res (2009)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma

Por Liapis, Vasilios, Zysk, Aneta, DeNichilo, Mark, Zinonos, Irene, Hay, Shelley, Panagopoulos, Vasilios, Shoubridge, Alexandra, Difelice, Christopher, Ponomarev, Vladimir, Ingman, Wendy, Atkins, Gerald J., Findlay, David M., Zannettino, Andrew C. W., Evdokiou, Andreas
Publicado no Cancer Med (2017)

The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF-κB Ligand (RANKL)-induced Osteoc...

Por Kogawa, Masakazu, Hisatake, Koji, Atkins, Gerald J., Findlay, David M., Enoki, Yuichiro, Sato, Tsuyoshi, Gray, Peter C., Kanesaki-Yatsuka, Yukiko, Anderson, Paul H., Wada, Seiki, Kato, Naoki, Fukuda, Aya, Katayama, Shigehiro, Tsujimoto, Masafumi, Yoda, Tetsuya, Suda, Tatsuo, Okazaki, Yasushi, Matsumoto, Masahito
Publicado em 2013